Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Interest & Investment Income (2015 - 2026)

Updated

Abvc Biopharma (ABVC) reported Interest & Investment Income of $2,384 for Q3 2026, down 95.0% from $47,287 a year earlier but up 249.0% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Interest & Investment Income (2015 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Abvc Biopharma's Interest & Investment Income came in at $88,438, down 9.2% year-over-year; for FY2025, it was $167,103, up 91.3% from FY2024.

  • Interest & Investment Income has a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $87,358 in FY2024 (-52.9%), $185,481 in FY2023 (-1.2%), $187,817 in FY2022 (+334.8%) and $43,196 in FY2021 (-39.2%).
  • Five-year quarterly Interest & Investment Income spans a low of -$29,388 in Q4 2021 and a high of $81,606 in Q4 2025.
  • Year over year, Interest & Investment Income has now declined in each of the last three quarters, with growth averaging 74.2% over the last eight quarters.
  • The high point for year-over-year Interest & Investment Income in five years was Q4 2025 (growth of 585.4%); the low point was Q2 2026 (a decline of 96.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $683.00 (Q2 2026), $3,765 (Q1 2026) and $81,606 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 186.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Abvc Biopharma 24.28 Mn 21.86 Mn - 2,384.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2,384.00
Jun 30, 2026 683.00
Mar 31, 2026 3,765.00
Dec 31, 2025 81,606.00
Sep 30, 2025 47,287.00
Jun 30, 2025 19,139.00
Mar 31, 2025 19,071.00
Dec 31, 2024 11,907.00
Sep 30, 2024 44,261.00
Jun 30, 2024 27,141.00
Mar 31, 2024 4,049.00
Dec 31, 2023 37,483.00
Sep 30, 2023 40,246.00
Jun 30, 2023 55,041.00
Mar 31, 2023 52,711.00
Dec 31, 2022 60,463.00
Sep 30, 2022 48,164.00
Jun 30, 2022 39,015.00
Mar 31, 2022 40,175.00
Dec 31, 2021 -29,388.00
API Access

Abvc Biopharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABVC&period=max&api_key=YOUR_API_KEY